The objective of this study was to investigate the reversal effect of Chinese herbs of Shenghe Powder on the multidrug resistance of the human SGC-7901 gastric carcinoma cell line and vincristine-resistant cell line (SGC-7901/vincristine) and the possible mechanism. SGC-7901 and SGC-7901/ vincristine were cultured in liquid medium RMPI 1640, with the addition of vincristine to the vincristine-resistant line. The reversal effect of Shenghe Powder (using verapamil as control) on the multidrug resistance of SGC-7901/vincristine cells was observed using the 3-4,5-dimethylthiazol-2yl) -2,5-diphenylterazolium bromide method. The expression rate of P-glycoprotein (P-gp), lymphoma/leukemia-2 (Bcl-2), and apoptosis ratio of SGC-7901 and SGC-7901/vincristine with added Shenghe Powder, verapamil, or verapamil plus Shenghe Powder was observed by flow cytometry. Shenghe Powder and verapamil decreased the multidrug resistance of SGC-7901/vincristine. The effect of Shenghe Powder (10 mg/L) was significantly higher than verapamil (P < .05). The intracellular concentration of vincristine was increased by Shenghe Powder and verapamil. The vincristine concentration of SGC-7901/vincristine treated with Shenghe Powder was significantly higher (P < .05). Shenghe Powder reduced the expression level of P-gp and Bcl-2 in SGC-7901/ vincristine and increased the apoptotic percentage of tumor cells; Shenghe Powder had the more significant effect on apoptosis (P < .05). In conclusion, Shenghe Powder increases the intracellular concentration of vincristine, consistent with the down-regulation of the expression of P-gp and Bcl-2. The reversal effect of Shenghe Powder was stronger than that of verapamil.
Lage H.MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance. Curr Drug Targets. 2006;7:813-821.
2.
Madureira AM, Ferreira MJ, Gyémánt N., et al. Rearranged jatrophane-type diterpenes from Euphorbia species: evaluation of their effects on the reversal of multidrug resistance. Planta Med.2004;70:45-49.
3.
Van Brussel JP, Oomen MA, Vossebeld PJ, et al. Identification of multidrug resistance-associated protein 1 and glutathione as multidrug resistance mechanisms in human prostate cancer cells: chemosensitization with leukotriene D4 antagonists and buthionine sulfoximine. BJU Int.2004;93:1333-1338.
4.
Wang JH, Xia YSEffect of Shenghe Powder on expression of Bcl-2 in gastric cancer. Practical J Med Pharm. 2005;22:621-622.
5.
Xia YS, Wang JH, Wu YZInducing differentiation effect of Shenghe Powder on C6 brain glioma cells . Lishizhen Med Materia Medica Res. 2007;18:290-291.
6.
Xia YS, Wang JH, Wu YZ, Liu X.Influence of Shenghe Powder with chemotherapy on recurrence and metastatic rate of operative gastric cancer. Chin J Surg Integr Tradit WestMed.1996;2: 402-405.
7.
Xia YS, Wang JH, Wu YZ, Song XR, Liu X.Clinical study on treating liver metastases from digestive tract cancer with Shenghe Powder combined with interventional therapy. Lishizhen Med Materia Medica Res. 2001;10:452-454.
8.
Ozben T.Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett.2006;580:2903-2909.
9.
Nobili S., Landini I., Giglioni B., Mini E.Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets. 2006;7:861-879.
10.
Di Nicolantonio F., Mercer SJ, Knight LACancer cell adaptation to chemotherapy. BMCCancer. 2005;5:78.
11.
Zhu B., Liu GT, Zhao YM, Wu RS, Strada SJChemosensitizing multiple drug resistance of human carcinoma by Bicyclol involves attenuated P-glycoprotein, GST-P and Bcl-2. Cancer Biol Ther . 2006;5:536-543.
12.
Gan HZ, Zhang GZ, Zhao JS, et al. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors. Chin Med J.2005;118:893-902.
13.
Zalipsky S. , Saad M., Kiwan R., et al. Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: insights of the mechanism of action. J Drug Target. 2007; 15:518-530.
14.
O'Connor R.The pharmacology of cancer resistance. Anticancer Res.2007;27:1267-1272.
15.
Yague E., Arance A., Kubitza L., et al. Ability to acquire drug resistance arises early during the tumorigenesis process. Cancer Res.2007;67:1130-1137.
16.
Manuguerra M., Matullo G., Veglia F., et al. Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions. Carcinogenesis. 2007;28:414-422.
17.
Song XR, Hou SXResearch progress in the reversion of traditional Chinese medicine on multidrug resistance of tumor. China J Chin Materia Medica. 2005;30:1300-1304.
